Boardroom Alpha
Boardroom Alpha
HUM · Additional Proxy Materials (DEFA14A) · Filed March 6, 2026

Humana Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 6, 2026
Ticker
HUM
Accession
0001104659-26-024398
Boardroom Alpha · Filing insights

Humana's DEF 14A shows the board’s voting recommendations for the 2026 AGM: items 1–4 for, item 5 against; meeting Apr 16, 2026.

About Humana Inc
Market cap
$38.5B
1Y TSR
+24.7%
3Y TSR
−14.4%
Board grade
C-
Sector
Healthcare
CEO
James A Rechtin
Last annual meeting: Apr 16, 2026 · View full Humana Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) 

of the Securities Exchange Act of 1934

(Amendment No.     )

 

Filed by the Registrant  x

 

Filed by a Party other than the Registrant ¨

 

Check the appropriate box:

 

¨ Preliminary Proxy Statement ¨ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2))
¨ Definitive Proxy Statement
x Definitive Additional Materials
¨ Soliciting Material Pursuant to §240.14a-12

 

Humana Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

¨Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

 

¨

Fee paid previously with preliminary materials.

 

 

 

 

 

 

On March 6, 2026, Humana Inc. (the “Company”) made the following communication available to the Company’s employees:

 

Highlights

 

·You may have the right to vote on items being presented at our Annual Meeting of Stockholders (the “Annual Meeting”)

 

·The Company’s Annual Meeting is scheduled for April 16, 2026 at 1:00 p.m. Eastern Time, and will be held via a live audio webcast accessible at: www.virtualshareholdermeeting.com/HUM2026

 

Exercise your voting privilege as a Humana stockholder

 

Humana associates who participate in our Company’s Retirement Savings Plan 401(k) and have invested funds in the Humana Common Stock Fund have the right to vote on items being presented at this year’s Annual Meeting, scheduled for April 16, 2026. You may submit one vote for each share held in your Humana Common Stock account as of February 27, 2026, the record date for this Annual Meeting.

 

What documents do you need to vote?

 

Every year, Humana produces a document - the proxy statement - that details all of the information the Company’s stockholders need in order to make informed votes. The proxy becomes available to stockholders and the public after Humana files it with the federal Securities and Exchange Commission on March 6, 2026. In order to vote, you must also receive an official “voting card.”

 

When will you receive the proxy statement and voting card?

 

Starting March 6, 2026, all stockholders who have (recently or in prior years) successfully submitted electronic requests for a proxy statement and voting card will then receive - via the e-mail address you designated during the online-registration process - a proxy statement and voting card. (Please watch for e-mail from ID@ProxyVote.com.) If you did not sign up for electronic delivery of these materials, you’ll receive a “Notice and Access Card” in the mail at home regarding the material.

 

When can participants in the Humana Retirement Savings Plan vote?

 

If you wish to vote, you may do so AFTER you receive your voting card. You then must vote BEFORE 11:59 p.m., EDT on Wednesday, April 8, 2026, through Humana’s Retirement Savings Plan Trustee - Charles Schwab - with Broadridge acting as tabulator. If your voting instructions are received by 11:59 p.m. EDT on Wednesday, April 8, 2026, the Trustee will submit a proxy that reflects your instructions. If you do not give voting instructions (or give them late), the Trustee will vote your interest in the Humana Common Stock Fund in the same proportion as the shares attributed to the Humana Retirement Savings Plan actually voted. Humana’s Annual Meeting will be held on April 16, 2026.

 

Whom do you contact for answers to your stockholder-voting-process questions?

 

If you have any questions, please contact Valerie M. Talkers, Corporate Secretary via email at CorporateSecretary@humana.com.

 

On March 6, 2026, the Company distributed the following “Notice Regarding the Availability of Proxy Materials” to its stockholders as of the record date of February 27, 2026.

 

 

 

 

GRAPHIC

Your Vote Counts! HUMANA INC. 2026 Annual Meeting Vote by April 15, 2026 11:59 PM ET You invested in HUMANA INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on April 16, 2026. Vote Virtually at the Meeting* April 16, 2026 1:00 p.m., Eastern Time Virtually at: www.virtualshareholdermeeting.com/HUM2026 *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V83468-P45111 Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 2, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. HUMANA INC. 101 EAST MAIN STREET 10TH FLOOR LOUISVILLE, KY 40202 ATTN: VALERIE M. TALKERS

GRAPHIC

THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V83469-P45111 1. Election of Directors Nominees: 1a. Raquel C. Bono, M.D. For 1b. Frank A. D’Amelio For 1c. David T. Feinberg, M.D. For 1d. Wayne A. I. Frederick, M.D. For 1e. Kurt J. Hilzinger For 1f. Karen W. Katz For 1g. Marcy S. Klevorn For 1h. Jorge S. Mesquita For 1i. James A. Rechtin For 1j. Gordon Smith For 2. The ratification of the appointment of Pricewater-houseCoopers LLP as the Company’s independent registered public accounting firm. For 3. Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. For 4. The approval of the Humana Inc. 2026 Stock Incentive Plan. For 5. The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. Against At their discretion, the Proxies are authorized to vote upon any other matters as may come before the Annual Meeting.

 

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Humana Inc (HUM)

Reference

Frequently asked questions

When did Humana Inc file this DEFA14A?
Humana Inc (HUM) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 6, 2026. The accession number assigned by EDGAR is 0001104659-26-024398.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Humana's DEF 14A shows the board’s voting recommendations for the 2026 AGM: items 1–4 for, item 5 against; meeting Apr 16, 2026. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Humana Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Humana Inc has filed under CIK 49071, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer